Tectonic Therapeutic TECX
NASDAQ TECX
$21.84 +0.01 (+0.07%)
At close: Oct 21, 2026 · 4:00 PM EDT

Tectonic Therapeutic (TECX) Research & Development (2017 - 2026)

Updated

Tectonic Therapeutic's Research & Development came in at $18.05 million for Q2 2026, up 5.0% from $17.19 million a year earlier but down 13.5% from the prior quarter.

Analysis

Tectonic Therapeutic (TECX) Research & Development (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Tectonic Therapeutic reported Research & Development of $72.19 million, up 34.4% year-over-year; for FY2025, it came in at $63.49 million, up 53.5% from FY2024.

  • Research & Development carries a five-year compound annual growth rate of -6.2% (FY2020 to FY2025).
  • Going back by year, Research & Development was $41.36 million in FY2024 (+11.9%), $36.97 million in FY2023 (-48.8%), $72.19 million in FY2022 (-13.1%) and $83.11 million in FY2021 (-4.7%).
  • The five-year range for quarterly Research & Development is $7.07 million (Q2 2024) to $23.04 million (Q3 2021).
  • Year-over-year, Research & Development has increased for eight consecutive quarters, with growth averaging 53.6% over the last eight quarters.
  • The fastest year-over-year change in Research & Development over five years came in Q2 2025 (growth of 142.9%), and the weakest in Q4 2023 (a decline of 60.3%).
  • Business Quant data shows TECX's Research & Development at $20.87 million (Q1 2026), $16.34 million (Q4 2025) and $16.93 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 3.65 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.34 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 4.05 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 1.76 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 2.81 Bn
10 Tectonic Therapeutic 410.19 Mn -576.04 Mn - 18.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.05 Mn
Mar 31, 2026 20.87 Mn
Dec 31, 2025 16.34 Mn
Sep 30, 2025 16.93 Mn
Jun 30, 2025 17.19 Mn
Mar 31, 2025 13.04 Mn
Dec 31, 2024 9.16 Mn
Sep 30, 2024 14.32 Mn
Jun 30, 2024 7.07 Mn
Mar 31, 2024 10.82 Mn
Dec 31, 2023 7.19 Mn
Sep 30, 2023 8.13 Mn
Jun 30, 2023 8.77 Mn
Mar 31, 2023 17.33 Mn
Dec 31, 2022 18.14 Mn
Sep 30, 2022 15.92 Mn
Jun 30, 2022 18.88 Mn
Mar 31, 2022 19.25 Mn
Dec 31, 2021 19.00 Mn
Sep 30, 2021 23.04 Mn
API Access

Tectonic Therapeutic Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=TECX&period=max&api_key=YOUR_API_KEY